Speaker
CuraCell Holding AB
Lucas Arruda, CuraCell Holding AB, is speaking at 8th TIL Therapies Summit 2026 (Boston, United States of America, 17–19 Nov 2026) in the session “Advancing TIL Clinical Development by Generating Early Efficacy Signals in Cold Solid Tumors”.
17–19 Nov 2026Boston, United States of America
CTMC
Texas Tech University Health Sciences Center
Hongzhou Huasai Biomedicine
University of Colorado
NEOGAP Therapeutics AB
Stanford University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Lucas Arruda, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].